Project Sc(y)lla Characterization: SARS-Cov-2 Large-scale Longitudinal Analyses on the comparative safety and effectiveness of treatments under evaluation for COVID-19 across an international observational data network
PLEASE NOTE: All results are preliminary and subject to change
The aim of this study is to characterize all emerging drug therapies used in COVID-19 treatment.
Specifically, the study aims to chararacterize:
- Treatments administered during hospitalization and prior to intensive services
- Treatments administered during hospitalization after initiating intensive services
- Treatments administered after COVID-19 positive testing or diagnosis in outpatient setting without prior hospitalization